Expression level of valosin-containing protein is strongly associated with progression and prognosis of gastric carcinoma

Journal of Clinical Oncology

Volumn 21, Issue 13, 2003, Pages 2537-2544

  Yamamoto, Shinji ^a   Tomita, Yasuhiko ^a   Hoshida, Yoshihiko ^a   Takiguchi, Shuji ^a   Fujiwara, Yoshiyuki ^a   Yasuda, Takushi ^a   Yano, Masahiko ^a   Nakamori, Shoji ^a   Sakon, Masato ^a   Monden, Morito ^a   Aozasa, Katsuyuki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VALOSIN CONTAINING PROTEIN; CDC48 PROTEIN; CELL CYCLE PROTEIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CARCINOMA; TUMOR VOLUME; BIOSYNTHESIS; CARCINOMA; DISEASE COURSE; GASTRECTOMY; GENE EXPRESSION REGULATION; GENETICS; METASTASIS; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CELL CYCLE PROTEINS; DISEASE PROGRESSION; FEMALE; GASTRECTOMY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL;

EID: 0038013984     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.12.102     Document Type: Article

References (30)

1. Parkin DM, Whelan SL, Ferlay J, et al (eds): Cancer Incidence in Five Continents (vol VII). Lyon, France, International Agency for Research on Cancer, 1997, pp 332-445
2. Lambert R, Guilloux A, Oshima A, et al: Incidence and mortality from stomach cancer in Japan, Slovenia and the USA. Int J Cancer 97:811-818, 2002
3. Roder JD, Stein HJ, Bottcher K, et al: Surgical therapy for gastric cancer. J Infus Chemother 5:97-103, 1995
4. Maehara Y, Oshiro T, Endo K, et al: Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence. Surgery 119:397-402, 1996
5. Okada Y, Fujiwara Y, Yamamoto H, et al: Genetic detection of lymph node micrometastases in patients with gastric carcinoma by multiple-marker reverse transcriptase-polymerase chain reaction assay. Cancer 92:2056-2064, 2001
6. Fukagawa T, Sasako M, Mann GB, et al: Immunohistochemically detected micrometastases of the lymph nodes in patients with gastric carcinoma. Cancer 92:753-760, 2001
7. Karpeh MJ, Brennan MF: Progress in the management of gastric cancer. Curr Opin Gen Surg:125-130, 1994
8. Sobin LH, Wittekind CH: TNM Classification of Malignant Tumours (ed 5). New York, NY, John Wiley & Sons, 1997, pp 59-62
9. Asai T, Tomita Y, Nakatsuka S, et al: VCP (p97) regulates NF-kappa-B signaling pathway, which is important for metastasis of osteosarcoma cell line. Jpn J Cancer Res 93:296-304, 2002
10. Dai RM, Chen E, Longo DL, et al: Involvement of valosin-containing protein, an ATPase co-purified with I-kappa-B-alpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of I-kappa-B-alpha. J Biol Chem 273:3562-3573, 1998
11. Yamamoto S, Tomita Y, Nakamori S, et al: Elevated expression of VCP (p97) in hepatocellular carcinoma correlates with increased incidence of tumor recurrence. J Clin Oncol 21:447-451, 2003
12. Stacker SA, Achen MG, Jussila L, et al: Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2:573-583, 2002
13. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma: 2nd English edition. Gastric Cancer 1:10-24, 1998
14. Muller JM, Meyer HH, Ruhrberg C, et al: The mouse p97 (CDC48) gene: Genomic structure, definition of transcriptional regulatory sequences, gene expression, and characterization of a pseudogene. J Biol Chem 274:10154-10162, 1999
15. Kaplan EL, Meier P: Non-parametric estimation for incomplete observations. J Am Stat Assoc 53:457-481, 1958
16. Cox DR: Regression models and life tables. J R Stat Soc 34:187-220, 1972
17. Kikuchi S, Sakakibara Y, Sakuramoto S, et al: Recent results in the surgical treatment of gastric cancer according to the Japanese and TNM classification. Anticancer Res 21:3589-3593, 2001
18. D'Ugo D, Pacelli F, Persiani R, et al: Impact of the latest TNM classification for gastric cancer: Retrospective analysis on 94 D2 gastrectomies. World J Surg 26:672-677, 2002
19. Fujino MA, Morozumi A, Kojima Y, et al: Gastric carcinoma, an endoscopically curable disease. Bildgebung 61:38-40, 1994 (suppl 1)
20. Sano T, Sasako M, Kinoshita T, et al: Recurrence of early gastric cancer: Follow-up of 1475 patients and review of the Japanese literature. Cancer 72:3174-3178, 1993
21. Martin HM, Filipe MI, Morris RW, et al: p53 expression and prognosis in gastric carcinoma. Int J Cancer 50:859-862, 1992
22. Lim BH, Soong R, Grieu F, et al: p53 accumulation and mutation are prognostic indicators of poor survival in human gastric carcinoma. Int J Cancer 69:200-204, 1996
23. Shiozaki H, Tahara H, Oka H, et al: Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol 139:17-23, 1991
24. Oliveira C, Seruca R, Seixas M, et al: The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different "target genes": A study of the TGF-beta RII, IGFII R, and BAX genes. Am J Pathol 153:1211-1219, 1998
25. Russo A, Bazan V, Migliavacca M, et al: DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: Results of a 5-year Gruppo Oncologico dell'Italia Meridonale (GDIM) prospective study. Cancer 92:294-302, 2001
26. Fiocca R, Luinetti O, Villani L, et al: Molecular mechanisms involved in the pathogenesis of gastric carcinoma: Interactions between genetic alterations, cellular phenotype and cancer histotype. Hepatogastroenterology 48:1523-1530, 2001
27. Mayo MW, Baldwin AS: The transcription factor NF-kappa-B: Control of oncogenesis and cancer therapy resistance. Biochim Biophys Acta 1470:M55-M62, 2000
28. Andela VB, Schwarz EM, Puzas JE, et al: Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappa B. Cancer Res 60:6557-6562, 2000
29. Sasaki N, Morisaki T, Hashizume K, et al: Nuclear factor-kappa B p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res 7:4136-4142, 2001
30. Macdonald JS, Smalley SR, Benedetti J, et al: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725-730, 2001